AKT1 and breast cancer: In support of that, vitamin D3 and melatonin, when simultaneously administered to MCF7 breast cancer cells, can induce TGFβ activation, a reduction in AKT phosphorylation and MDM2, increasing the p53/MDM2 ratio and inducing cell cycle arrest, suggesting a synergic effect [148].